# Recall by Genotype: Neuropeptide Stimulation

> **NCT05901467** · PHASE1 · TERMINATED · sponsor: **Stephanie B. Seminara, MD** · enrollment: 16 (actual)

## Conditions studied

- Reproductive Disorder

## Interventions

- **DRUG:** kisspeptin 112-121
- **DRUG:** GnRH

## Key facts

- **NCT ID:** NCT05901467
- **Lead sponsor:** Stephanie B. Seminara, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-10-20
- **Primary completion:** 2024-05-29
- **Final completion:** 2024-05-29
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** The study team no longer has access to GnRH. The study has been altered to account for this change and is no longer a clinical trial.
- **Last updated:** 2026-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05901467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05901467, "Recall by Genotype: Neuropeptide Stimulation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05901467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*